| # | Program | Focus | Medications (May 2026 profile unless dated) | Price and read date | Score |
|---|---|---|---|---|---|
| 1 | NexLife | GLP-1 / weight loss (compounded) | Compounded semaglutide and tirzepatide | Compounded semaglutide $95 and tirzepatide $115 a month on 12-month plans ($109 and $129 month to month); same price at every dose, no membership (nexlife.us, read November 6, 2026). | 86/100 (v4.1) |
| 2 | Eden Health | GLP-1 / Weight Loss | Semaglutide, Tirzepatide | Compounded tirzepatide $129 and semaglutide $99 a month at every dose, with no membership fee (eden.health, read November 20, 2026). | 78/100 (v4.1, November 20, 2026) |
| 3 | Found | GLP-1 / weight loss | Compounded semaglutide and tirzepatide; brand GLP-1s through insurance | Compounded semaglutide, cash pay: $149 for the first 28-day cycle, then $269 month to month, or $199, $179 and $149 per cycle on 3-, 6- and 12-month terms; tirzepatide $339 month to month and $199 on 12 months (joinfound.com, read November 20, 2026). | 75/100 (v4.1, November 20, 2026) |
| 4 | Sequence (WW Clinic) | GLP-1 / weight loss (WeightWatchers clinic) | Brand GLP-1s (Wegovy, Zepbound and pills); medication billed separately | $25 for the first month, then a $74 monthly membership on a 12-month plan ($84 on 6 months); GLP-1 medication is not included (weightwatchers.com, read November 20, 2026). | 72/100 (v4.1, November 20, 2026) |
| 5 | Mochi Health | GLP-1 / weight loss | Brand GLP-1s (Wegovy, Zepbound, Wegovy pill, Foundayo, Ozempic, Mounjaro) and compounded GLP-1s | Health membership $79 a month, or $49 a month on a 12-month plan, plus medication priced by dose: compounded semaglutide from $60 and tirzepatide from $90 at the starting dose (joinmochi.com, read November 20, 2026). | 68/100 (v4.1, November 20, 2026) |
| 6 | Form Health | GLP-1 / weight loss (insurance-first) | Brand GLP-1s billed through insurance (May 2026 profile) | A self-pay plan of $299 a month covers clinician and dietitian visits when insurance does not cover the program; medication is billed separately through insurance (formhealth.co FAQ, read November 20, 2026). | 67/100 (v4.1, November 20, 2026) |
| 7 | LifeMD | GLP-1 / Primary Care | Semaglutide, Tirzepatide | Wegovy pen from $199 and Zepbound vials from $299, plus a program and provider fee of $149 a month ($39 the first month); the page's structured data says $75 a month on an annual plan (lifemd.com, read November 20, 2026). | 64/100 (v4.1, November 20, 2026) |
| 8 | Calibrate | GLP-1 / weight loss (brand medication with coaching) | Brand GLP-1s (Wegovy and others, per May 2026 profile) | $199 a month with a 3-month commitment, then month to month; prescription medication and lab tests are not included (joincalibrate.com/pricing, read November 20, 2026). | 64/100 (v4.1, November 20, 2026) |
| 9 | Noom Med | GLP-1 / weight loss with a behavior program | GLP-1s including microdose compounded semaglutide and tirzepatide; brand options | Compounded semaglutide $129 for the first 4 weeks, then $249 a month billed quarterly (a footnote says $279 a month, billed $837 every 12 weeks); tirzepatide $149, then $299 a month (noom.com/med/pricing, read November 20, 2026). | 56/100 (v4.1, November 20, 2026) |
| 10 | Henry Meds | GLP-1 / weight loss | Compounded GLP-1s (May 2026 profile) | Its price list (dated December 3, 2025) shows compounded semaglutide at $297 a month for up to 10 mg every 70 days, or $2,364 for 12 months paid in full; no injectable tirzepatide price is printed (henrymeds.com, read November 20, 2026). | 53/100 (v4.1, November 20, 2026) |
| – | Hims & Hers | GLP-1 / weight loss (mass-market telehealth) | Compounded and brand GLP-1s (May 2026 profile) | Not re-read: hims.com returned HTTP 403 to our reads on November 20, 2026, so Hims & Hers is not scored this round. | Not scored (May 2026, v3.0) |
| – | Ro Body | GLP-1 / weight loss (brand medication) | Brand GLP-1s (May 2026 profile) | Not re-read: ro.co returned HTTP 403 to our reads on November 20, 2026, so Ro is not scored this round and no Ro price is shown as current. | Not scored (May 2026, v3.0) |
Peptide and hormone clinics (May 2026 profiles)
These clinics keep their May 2026 profiles under the older v3.0 rubric. They were not re-scored on the v4.1 methodology in this update and are not part of the GLP-1 ranking above, so their scores should not be compared with it. FDA’s warning-letter index lists letters to Belle Health (February 20, 2026) and Maximus (June 8, 2026); see their pages.
| # | Program | Focus | Medications (May 2026 profile unless dated) | Price and read date | Score |
|---|---|---|---|---|---|
| – | Belle Health | GLP-1 / Weight Loss | Semaglutide, Tirzepatide | Price not re-read (May 2026 profile). | 72/100 (May 2026, v3.0) |
| – | BreezeMeds | GLP-1 + Longevity | Semaglutide, Tirzepatide, NAD+ | “Starting at $199” for weight-loss injections; the molecule is not named (breezemeds.com, read November 20, 2026). | 68/100 (May 2026, v3.0) |
| – | Defy Medical | Multi-specialty (Hormones, Peptides, Longevity) | Tirzepatide, BPC-157, CJC-1295 / Ipamorelin, NAD+, Sermorelin, PT-141 | Price not re-read (May 2026 profile). | 88/100 (May 2026, v3.0) |
| – | Heally | Multi-specialty (Peptides + GLP-1) | BPC-157, Semaglutide, Tirzepatide, TB-500, CJC-1295 / Ipamorelin | Price not re-read (May 2026 profile). | 70/100 (May 2026, v3.0) |
| – | Hone Health | Hormone Optimization (Male-focused) | Semaglutide, Tirzepatide, CJC-1295 / Ipamorelin, BPC-157, Sermorelin | Price not re-read (May 2026 profile). | 80/100 (May 2026, v3.0) |
| – | Marek Health | Multi-specialty (Hormones, Peptides, Longevity) | BPC-157, TB-500, CJC-1295 / Ipamorelin, Tesamorelin, NAD+, Sermorelin | Price not re-read (May 2026 profile). | 85/100 (May 2026, v3.0) |
| – | Maximus | Men's Health (Performance + Hormones) | CJC-1295 / Ipamorelin, Semaglutide, Sermorelin, BPC-157, NAD+ | Price not re-read (May 2026 profile). | 76/100 (May 2026, v3.0) |
| – | PeterMD | Multi-specialty (Peptides + Cognitive) | BPC-157, Sermorelin, CJC-1295 / Ipamorelin, Semax, Selank | Price not re-read (May 2026 profile). | 71/100 (May 2026, v3.0) |
| – | PlushCare | GLP-1 / Primary Care | Semaglutide, Tirzepatide | Price not re-read (May 2026 profile). | 73/100 (May 2026, v3.0) |
| – | Sesame | Quick-access GLP-1 | Semaglutide, Tirzepatide | Price not re-read (May 2026 profile). | 68/100 (May 2026, v3.0) |
How to use this directory
Start with what you want treated and whether you need a brand drug, which insurance or the manufacturer’s self-pay programs may cover, or accept a compounded one, which is not FDA-approved. Then open each review: it shows what we could verify, what we could not, and five checks to run before you pay. Our brand GLP-1 program-fee analysis and red-flag checklist help with the next step.